SCHEMBL16405692

SCHEMBL16405692

Nc1ccc(-c2ccc(N)cc2-c2ccncc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 2/20 0.50
MAPT P10636 3/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MEN1 O00255 1/20 0.48
CYP2D6 P10635 1/20 0.48
CHRM1 P11229 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
KMT2A Q03164 1/20 0.48
KCNA1 Q09470 1/20 0.48
GCGR P47871 1/20 0.47
MAPK14 Q16539 1/20 0.47
CYP3A4 P08684 3/20 0.47
CYP17A1 P05093 2/20 0.47
CYP19A1 P11511 2/20 0.47
CYP11B1 P15538 2/20 0.47
CYP11B2 P19099 2/20 0.47
NTRK1 P04629 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16405694 0.91 IMPDH2 (0.53) IMPDH2MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL16405699 0.89 IMPDH2 (0.45) IMPDH2MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL30880329 0.87 ALDH1A1 (0.53) MAPTALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL14110641 0.87 ALDH1A1 (0.53) MAPTALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL16405702 0.85 CYP46A1 (0.46) IMPDH2MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL28349056 0.82 ALDH1A1 (0.53) MAPTALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL16405698 0.81 CYP46A1 (0.46) IMPDH2MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL27777760 0.81 IMPDH2 (0.51) IMPDH2MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL1883277 0.81 IMPDH2 (0.51) IMPDH2MAPTALDH1A1LMNASMN1; SMN2
SCHEMBL16405691 0.80 MKNK1 (0.56) MAPTALDH1A1MEN1CYP3A4CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9353222-B2 Composition, polymer film, and display device SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-05-31 US disclosed
US-9353222-B2 Composition, polymer film, and display device SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-05-31 US disclosed
US-20150025200-A1 COMPOSITION, POLYMER FILM, AND DISPLAY DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-01-22 US disclosed
US-20150025200-A1 COMPOSITION, POLYMER FILM, AND DISPLAY DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150025200-A1 COMPOSITION, POLYMER FILM, AND DISPLAY DEVICE DDT, DTD1, DRD1 IMPDH2 2464/4885MAPT 406/4885ALDH1A1 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.